image
Bellerophon Therapeutics, Inc. BLPH
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.037
0 %
$ 453 K
Market Cap
-0.04
P/E
BALANCE SHEET
7.94 M ASSETS
-70.47%
Growth Rates
1Year -70.47%
3Years -15.41%
5Years -26.43%
7Years -20.17%
10Years 9.01%
5.4 M LIABILITIES
2.76%
Growth Rates
1Year 2.76%
3Years -17.21%
5Years -32.80%
7Years -5.58%
10Years -9.38%
2.53 M EQUITY
-88.28%
Growth Rates
1Year -88.28%
3Years -10.97%
5Years 24.38%
7Years -29.86%
10Years 8.34%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Bellerophon Therapeutics, Inc.
image
Current Assets 7.56 M
Cash & Short-Term Investments 7.33 M
Receivables 0
Other Current Assets 234 K
Non-Current Assets 372 K
Long-Term Investments 0
PP&E 186 K
Other Non-Current Assets 186 K
Current Liabilities 5.4 M
Accounts Payable 1.23 M
Short-Term Debt 203 K
Other Current Liabilities 3.97 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 6.9 24.7 47.6 9.9 16.6 28.8 14.5 6.3 16.8 0 0
Short Term Investments 0.4 0 0 0 0 3.0 5.6 17.8 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.2 0.7 0.5 0.5 0.8 3.8 6.7 10.8 10.9 1.6 0.3
Total Current Assets 7.6 25.5 48.1 10.4 17.4 35.6 26.5 29.5 27.7 1.6 0.3
PP&E 0.2 0.9 1.7 2.4 0.7 1.0 1.4 1.8 1.7 2.1 1.7
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.3 0.3 0.3 0.3 0.1 0.3 0 0 0 0
Other Long Term Assets 0.2 0.2 0.2 0 0 54 K 1.5 7.2 4.0 0 1.3
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 7.9 26.9 50.2 13.1 18.4 36.8 29.7 38.4 33.4 3.6 3.3
LIABILITIES
Accounts Payable 1.2 1.2 3.7 3.1 2.8 3.9 2.8 1.6 0.4 1.4 1.5
Short Term Debt 0.2 1.5 1.4 1.3 0 0 0 0 0 0 0
Other Current Liabilities 4.0 2.4 5.3 3.2 4.8 3.2 3.7 6.5 10.1 12.6 9.7
Total Current Liabilities 5.4 5.1 10.4 7.6 7.5 7.1 6.5 8.1 10.5 14.0 11.2
Long Term Debt 0 0.2 1.0 1.7 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 1 K 0.6 0.3 7.0 32.3 5.2 0 0 5.4 3.3
Total Liabilities 5.4 5.3 12.0 9.5 14.5 39.4 11.7 8.1 10.5 19.4 14.5
EQUITY
Common Stock 96 K 95 K 95 K 46 K 0.6 0.6 0.3 0.1 0 0 0
Retained Earnings (252.1) (232.2) (214.5) (189.8) (176.5) (179.3) (124.5) (100.7) (54.2) (176.5) (114.5)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 4 K 0 19 K (1.2) (0.9) (0.2)
Total Equity 2.5 21.6 38.2 3.6 3.9 (2.6) 18.0 30.3 22.9 (15.7) (11.1)
Total Liabilities and Equity 7.9 26.9 50.2 13.1 18.4 36.8 29.7 38.4 33.4 3.6 3.3
SHARES OUTSTANDING
Common Shares Outstanding 9.6 9.5 7.8 4.5 4.3 2.6 1.0 0.8 11.9 12.9 12.9